Activity Enhancer for Anticancer Agent
AssigneeTokyo University of Science Foundation
InventorsFumio Fukai, Hiroaki Kodama, Takuya Matsunaga
Life of this patent
Estimating the term…
Abstract
An activity enhancer for an anticancer agent includes, as an active ingredient, a D-form amino acid residue-containing FNIII14 polypeptide, the D-form amino acid residue-containing FNIII14 being a polypeptide FNIII14 represented by SEQ ID NO: 1 in which at least one of amino acid residues at positions 1 to 13 is a D-form amino acid residue. An anticancer composition includes the activity enhancer for an anticancer agent and an anticancer agent.
Claims11
An activity enhancer for an anticancer agent, comprising, as an active ingredient, a D-form amino acid residue-containing FNIII14 polypeptide, the D-form amino acid residue-containing FNIII14 being a polypeptide FNIII14 represented by SEQ ID NO:
- 1 in which at least one of amino acid residues at positions 1 to 13 is a D-form amino acid residue.
-4. (canceled)
A polypeptide that is either one of the following peptides:
- (a) a polypeptide which is represented by SEQ ID NO:
- 1, and in which at least one of amino acid residues at positions 1 to 13 is a D-form amino acid residue;
- or
- (b) a polypeptide which is a multimer, of which a constituent unit is the polypeptide (1).
Dependencies are inferred from the claim text.